TAG:
genomics
December 2, 2013 “Intelligence: Late-Breaking Lab News”
Despite the continuing cutbacks in reimbursement for lab testing, some professional investors still see opportunity in this market sector. On November 13, Genova Diagnostics, Inc., of Asheville, North Carolina, was acquired by Levine Leichtman Capital Partners and  
Frederick Sanger Dies at Age 95, Hailed as Father of Genomics
EVERY DAY, ACROSS THE GLOBE, labs perform testing using Sanger sequencing and other fundamental techniques of proteomics and genomics pioneered and developed by Frederick Sanger, who died last month at the age of 95. Sanger is considered one of the giants in biochemistry. He was one of only three pe…
Walgreens To Go National with Lab Tests in Stores
CEO SUMMARY: A disruptive innovation is one that shakes up an entire market or industry. By adding clinical lab testing to its health services offerings in more than 8,100 stores nationwide, Walgreens could disrupt the status quo in the clinical lab industry. Walgreens says its lab partne…
PathCentral Launches Sale of New Anatomic Pathology LIS
THERE IS A NEW PLAYER in the market for anatomic pathology laboratory information systems (APLIS). This gives pathology groups a new option when it is time to upgrade or replace their existing APLIS. It also brings a new competitor into the existing market for anatomic pathology (AP) software. In re…
Mass Spectrometry, Collaboration Produce Dramatic Results
CEO SUMMARY: When the Department of Pathology and Genomic Medicine at the Methodist Hospital in Houston, Texas, worked with the Pharmacy Services Department, the outcome was a dramatic reduction in the time needed to more accurately identify and treat the pathogens causing gram-negative b…
Experts Say Labs May Start to Receive MDx Payments
CEO SUMMARY: In the fourth month of the current year, there is plenty of confusion and uncertainty over how the Medicare program will establish prices for the new molecular CPT codes and when both government and private payers will begin to regularly reimburse laboratorie…
January 22, 2013 “Intelligence: Late Breaking Lab News”
Not-for-profit Boston Children’s Hospital will have majority interest in a new lab testing company. Claritas Genomics will be based in Waltham, Massachusetts, and will develop genetic and molecular diagnostic testing solutions. Life Technologies Corporation…
Ascend Clinical Acquires PathCentral Lab Business
CEO SUMMARY: Ascend Clinical and PathCentral see an opportunity to provide sophisticated services to community pathology groups. Ascend Clinical will expand the molecular diagnostic and gene sequencing business it is purchasing from PathCentral. PathCentral will concentrate on marketing i…
November 19, 2012 “Intelligence: Late Breaking Lab News”
Only one clinical lab industry vendor made the inaugural list of the Modern Healthcare’s fastest- growing health companies. It was Sysmex America, of Mundelein, Illinois. Sysmex ranked number 26 on a list of 40 healthcare companies. Modern Healthcare reported that…
October 29, 2012 “Intelligence: Late Breaking Lab News”
OURLab and its parent company, Prost Data, Inc., of Nashville, Tennessee, entered into an agreement to be sold to Opko Health Inc., of Miami, Florida. The purchase price of $40 million will be paid as $9.4 million in cash and $30.6 million in stock. …
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.